Michael McNeil is recorded as Chief Accounting Officer at Sanara MedTech Inc. (SMTI) since January 15, 2025 and CFO at Sanara MedTech Inc. (SMTI). Sanara MedTech Inc. reported in an 8-K filed May 23, 2025 that Michael McNeil retired as Chief Accounting Officer and Chief Administrative Officer, effective August 19, 2025. Sanara MedTech Inc. reported in an 8-K filed January 22, 2025 that Michael McNeil was appointed Chief Accounting Officer and Chief Administrative Officer, effective January 15, 2025. The proxy statement of Sanara MedTech Inc. reports total compensation of $529,260 for Michael McNeil in fiscal 2024, including a base salary of $225,000. Disclosed compensation is on record for 5 fiscal years. Michael McNeil has spoken on 5 earnings calls across 1 company, most recently for Sanara MedTech Inc. on November 12, 2024. Sanara MedTech Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Sanara MedTech Inc. includes Ronald T. Nixon (CEO), Seth D. Yon (CEO and Board Member), Seth Yon (CEO and Board Member) and 7 others.
“On May 19, 2025, Michael D. McNeil notified Sanara MedTech Inc. (the "Company") that he is retiring from his position as Chief Accounting Officer and Chief Administrative Officer of the Company, effective August 19, 2025 (the "Effective Date").”
Sanara MedTech Inc. Form 8-K, filed May 23, 2025
· Read the filing
“Ms. Taylor succeeds Michael McNeil, who has been appointed to serve as Chief Accounting Officer and Chief Administrative Officer.”
Sanara MedTech Inc. Form 8-K, filed January 22, 2025
· Read the filing
Michael McNeil on recent calls
“During the third quarter of 2024, Sanara generated net revenue of $21.7 million compared to $16 million in the third quarter of 2023, a 35% increase over the prior year period.”
“During the second quarter, Sanara generated net revenue of $20.2 million compared to $15.8 million during the second quarter of 2023, a 28% increase over the prior year period.”
“I'd like to discuss the new debt facility we recently announced with CRG. This transaction helped us strengthen our cash position and provided access to growth and acquisition capital in a way that was nondilutive to equity holders.”
“For the quarter, we generated revenues of $13 million compared to revenues of $5.8 million for the third quarter of 2021, representing a 124% increase from the prior year period.”
“For the three months ended June 30, 2022, we generated net revenues of $9.7 million compared to net revenues of $6.3 million for the three months ended June 30, 2021, representing a 54% increase from the prior-year period.”
